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Introduction
Gestational diabetes mellitus (GDM) does not usually begin until the second trimester of pregnancy, but it is extremely common and continues throughout pregnancy once it begins. Glucose intolerance and elevated blood glucose levels are key to the diagnosis of this pregnancy complication [1, 2] .The increase in obesity and older pregnancy age contribute to GDM's increasing prevalence, and public health systems bear this burden [3] . GDM may cause various complications for the offspring, including neonatal hypoglycemia, stillbirth, preterm birth, macrosomia, shoulder dystocia, and affect the mother in many ways, ranging from hypoglycemia to a need for caesarean section [4] . Besides these risks associated with pregnancy and delivery, women with GDM are also at increased risk for type 2 diabetes and cardiovascular diseases later in life [5] . The women at highest risk for GDM are those with a family history of type 2 diabetes, a previous personal history of GDM or a macrosomic infant, obesity, and those of advanced age [6] .
In the literature, the prevalence of GDM varies between 1.2 and 27.9% in different studies conducted regionally in Turkey [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Since there has been no multicenter study in our country, there is no data on the national prevalence of GDM today. The use of different diagnostic criteria may be associated with the detection of a wide prevalence range. For this reason, we aimed to investigate the prevalence of GDM in accordance with the criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) by using the data from a single center in Kayseri, which is a reference center in Turkey.
Materials and methods
Pregnant women between the ages of 18 and 45 who were referred to the clinic for routine pregnancy follow-up visits between January 2018 and 2019 at Kayseri City Hospital's Gynecology and Obstetrics Department were included in this study. Their records were obtained from the hospital registry and retrospectively examined. All research was conducted in accordance with the Helsinki Declaration, and ethics approval was obtained from Erciyes University Ethics Committee (No: 2019/616). Patients with previously diagnosed diabetes mellitus (type 1 and type 2), those with a history of endocrine diseases (Cushing's disease, Addison's disease, pituitary failure, acromegaly, etc.) or drug use that could affect blood glucose levels were excluded from the study. The date of last menstrual period was used to determine the gestational week of the patients. The gestational age of any patient who did not know the date of her last menstrual period was calculated according to ultrasonographic measurements performed in the first trimester. Patients were screened with single-stage 75-g OGTT, and the IADPSG criteria were used for diagnosis.
Inclusion criteria included the following risk factors for gestational diabetes: diabetes mellitus in the family, particularly in first degree relatives, a body mass index (BMI) >30 kg/m2 or excessive gestational weight gain, gestational diabetes or birth of a macrosomic baby >4.1 kg, a syndromic infant, unexplained perinatal loss in a previous pregnancy, a history of impaired glucose tolerance, glycosuria during prenatal examination, and conditions leading to diabetes, such as metabolic syndrome, polycystic ovary syndrome or actual use of glucocorticoids [21] Following 12 hours of fasting, the plasma glucose of the patients were measured, after which 75 mg glucose was ingested orally by the patients. Venous blood samples were obtained one and two hours later. The upper limit of plasma glucose values for fasting state, and at the first-and second hours following ingestion of glucose were 91, 179 and 152 mg/dL, respectively (Table 1) [22] . Any value crossing the threshold was considered positive. GDM prevalence was determined according to these one-step screening test results. 
Statistical analysis
For statistical analysis of the study data, PASW Statistics 18 (SPSS version 18, 2009, Chicago, IL, USA) was used, and percentages were determined. Data were expressed as mean (standard deviation), median (25-75%), or n (%). Descriptive statistics was performed.
Results
Two thousand, six hundred and fifty-two pregnant women were included in this study and screened for GDM with a single-step 75-g OGTT. The mean age of all pregnant women was 26.42 (22-31) years. The mean gravid, parity and gestational weeks at the time of testing were 3 (range 1-5), 3 (range 1-4), 26 (range 24-28), respectively. The demographic data, fasting, 60 th minute and 120 th minute plasma glucose levels are presented in Table 2 . Table 3 shows the prevalence of GDM and the higher rates of fasting, 60-min, and 120-min plasma glucose levels. The prevalence of GDM, detected in 424 of 2652 patients, was 16% (424/2652). 
Discussion
There is no clear international consensus on GDM screening and diagnosis. The World Health Organization and the Endocrine Society suggest a one-step approach using the IADPSG diagnostic criteria. The American College of Obstetricians and Gynecologists (ACOG) and the National Institutes of Health (NIH) suggest a two-step approach, while The American Diabetes Association (ADA) has stated that any one of the one-or two-step approaches may be used. In the literature, the prevalence of GDM in our country is reported as 1.2-27.9% [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . In our study, GDM screening with a single step 75g OGTT revealed that the prevalence in Kayseri was 16% according to the IADPSG criteria. The difference in GDM prevalence in different regions of our country may be caused by differences in dietary groups, nutritional status, age groups, and diverse diagnostic tests.
Although a large amount of research was conducted in central Anatolia in Turkey, the vast majority have been conducted in Ankara. In a study conducted by Altay et al. [14] with 6909 pregnant women in 2010, the prevalence of GDM was determined as 10.4%. They used two-step screening according to the National Diabetes Data Group (NDDG) criteria. Ozdemir et al. [16] prospectively researched GDM prevalence and found it to as 8.4% according to single-step screening and IADPSG criteria. The prevalence of GDM among 1434 pregnant women by Karcaaltıncaba et al. [18] revealed it as 11.1% according to IADPSG criteria with single-step screening. Recently, Ozgu et al. [19] found that the prevalence of GDM was 21% according to IADPSG criteria with single-step screening. The prevalence of GDM is increasing within Ankara, another reference city for the Central Anatolia region. In Kayseri, two-step screening of pregnant women in 2008 revealed that the prevalence of GDM, according to the NDDG criteria, was 6.2% [10] . The single-step GDM screening performed in accordance with the IADPSG criteria in the USA revealed 18% prevalence, which was at least twice as high as what was calculated in two-step screening following ACOG recommendations [23] . The high prevalence of GDM in Kayseri may be explained by the usage of the single-step screening method. Many risk factors, including obesity, increased urbanization, sedentary lifestyle, and advanced maternal age increase GDM prevalence. It has been shown that the prevalence of GDM in the province of Kayseri is higher than the other central regions of Turkey. GDM is an important health problem causing both maternal and perinatal complications with increasing incidence in our country and all over the world. This situation calls for immediate action: Improving maternal nutrition and exercise may decrease the rate of death of both mothers and infants due to GDM.
Limitations
The evaluation of the prevalence of GDM in a single center is the main limitation of our study, despite the fact the Kayseri City Hospital is a reference hospital. Additionally, we did not compare maternal demographic and delivery outcomes between GDM positive and negative groups, which is another limitation. Further studies are needed.
Conclusion
The prevalence of GDM was 16% according to the IADPSG criteria with a single-step 75-g OGTT in pregnant women in Kayseri.
